IBA (Ion Beam Applications S.A.) has entered into an agreement with Bayer Schering Pharma AG for chemical process development and clinical trial supply of Florbetaben, a molecular imaging compound in development for the detection of Alzheimer’s disease pathology. IBA will manufacture and supply Bayer and its trial partners with doses of the compound for clinical trials. IBA will develop a large-scale manufacturing process on Synthera, its multi-purpose automated synthesizer, and upgrade its po...